Logo

American Heart Association

  2
  0


Final ID: MDP1743

Peak Frequency Analysis Distinguishes Nearfield from Farfield Signals During Atrial Fibrillation Ablation

Abstract Body (Do not enter title and authors here): Background: The failure to distinguish nearfield and farfield signals is a common reason for ablation failure. Peak frequency (PF) analysis of electrograms is hypothesized to distinguish nearfield from farfield cardiac signals, although in vivo proof is lacking.

Hypothesis: Using electrically isolated pulmonary vein (PV) tissue for analysis, PF will distinguish nearfield from farfield electrograms during atrial fibrillation (AF) ablation, identifying successful PV isolation and validating PF as a predictor of catheter proximity to electrical signals (nearfield versus farfield).

Methods: We created a cohort of twenty patients with paroxysmal AF undergoing wide area circumferential PV isolation between July 2023 and January 2024. Left atrial and PV maps of PF (EnSite OT Near Field, Abbott, Inc) were generated before (Figure A) and after (Figure B) each PV isolation attempt and if dissociated potentials were present. The highest PF in each PV was selected in each PF map. PV electrograms were defined as farfield or nearfield based on the presence or absence of exit and entrance block. PV electrograms of dissociated potentials were considered nearfield. In the first 10 patients, a cutoff value was selected to predict nearfield versus farfield signals. The performance of this cutoff was assessed in the remaining 10 patients. If the PF remained elevated after PV isolation, pacing maneuvers were used to identify the source of the signal.

Results: PF was lower in isolated PVs compared to connected PVs or dissociated potentials within PVs (Figure C). In the derivation cohort, a PF of 300 Hz had 93.2% (95% CI 81.3% - 98.6%) sensitivity and 100% (95% CI 95.0% - 100.0%) specificity for identifying the signal as farfield. In the validation cohort, this cutoff was associated with 90.0% (95% CI 76.3% to 97.2%) sensitivity and 100.0% (95% CI 93.6% to 100.0%) specificity. All farfield signals with a PF over 300 Hz were SVC signals detected in the right superior PV.

Conclusions: PF distinguishes nearfield PV from farfield left atrial signals during AF ablation. PF analysis improves the recognition of PV isolation. Future studies modifying mapping and ablation strategies by utilizing PF as a tool to define nearfield versus farfield should be pursued to improve ablation outcomes.
  • Ting, Peter  ( NYU , New York , New York , United States )
  • Chinitz, Larry  ( NYU School of Medicine , New York , New York , United States )
  • Aizer, Anthony  ( NYU School of Medicine , New York , New York , United States )
  • Barbhaiya, Chirag  ( NYU School of Medicine , New York , New York , United States )
  • Jankelson, Lior  ( NYU School of Medicine , New York , New York , United States )
  • Holmes, Douglas  ( NYU School of Medicine , New York , New York , United States )
  • Kushnir, Alexander  ( NYU School of Medicine , New York , New York , United States )
  • Knotts, Robert  ( NYU School of Medicine , New York , New York , United States )
  • Yang, Felix  ( NYU School of Medicine , New York , New York , United States )
  • Bernstein, Scott  ( New York University , New York , New York , United States )
  • Park, David  ( NYU School of Medicine , New York , New York , United States )
  • Author Disclosures:
    Peter Ting: DO NOT have relevant financial relationships | Larry Chinitz: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Biosense Webster:Active (exists now) ; Consultant:Abbott:Active (exists now) | Anthony Aizer: DO have relevant financial relationships ; Consultant:Biotronik:Past (completed) ; Consultant:Abbott:Past (completed) ; Consultant:Medtronic:Past (completed) ; Consultant:Biosense Webster:Past (completed) ; Consultant:Boston Scientific:Past (completed) | Chirag Barbhaiya: No Answer | Lior Jankelson: No Answer | Douglas Holmes: No Answer | Alexander Kushnir: DO NOT have relevant financial relationships | Robert Knotts: No Answer | Felix Yang: No Answer | Scott Bernstein: No Answer | David Park: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Ablating Smarter: Back to Biophysics!

Monday, 11/18/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts on this topic:
Adverse Events with Pulsed Field Ablation - A Review of the Food and Drug Administration’s Manufacturer and User Facility Device Experience Database

Cooper Julie, Zagrodzky William, Zagrodzky Jason, Omotoye Samuel, Sardana Mayank, Kaplan Andrew, Link Mark, Bunch Thomas, Daniels James

A novel risk score predicts the prevalence of left atrial low-voltage areas and rhythm outcome in patients undergoing long-standing persistent atrial fibrillation ablation

Ooka Hirotaka, Nakao Sho, Kusuda Masaya, Ariyasu Wataru, Kudo Satoshi, Fujii Subaru, Mano Toshiaki, Matsuda Yasuhiro, Masuda Masaharu, Okamoto Shin, Ishihara Takayuki, Nanto Kiyonori, Tsujimura Takuya, Hata Yosuke, Uematsu Hiroyuki

More abstracts from these authors:
Individualized Ablation Strategies Optimize First Pass Isolation and Minimize Pulmonary Vein Reconnection During Atrial Fibrillation Ablation

Junarta Joey, Bernstein Scott, Park David, Chinitz Larry, Aizer Anthony, Qiu Jessica, Cheng Austin, Barbhaiya Chirag, Jankelson Lior, Holmes Douglas, Kushnir Alexander, Knotts Robert, Yang Felix

Performance of a Protein Language Model for Variant Annotation in Cardiac Disease

Hochstadt Aviram, Martin Jacob, Park David, Spinelli Michael, Chinitz Larry, Jankelson Lior, Barbahya Chirag, Aizer Anthony, Bernstein Scott, Cerrone Marina, Garber Leonid, Holmes Douglas, Knotts Robert, Kushnir Alex

You have to be authorized to contact abstract author. Please, Login
Not Available